Glenmark to conduct trials of potential Covid drug

Glenmark Pharmaceuticals on Thursday said it has become the first company in India to receive approval from DCGI to conduct clinical trials of Favipiravir antiviral tablets to treat COVID-19 patients. Having internally developed the API and the formulations for the product, the company received approval for conducting the trial on mild to moderate patients.

from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/3bQLFQg
>

Comments

Popular posts from this blog

BTS members Jin and Jungkook unveil their postcard messages to ARMY as they gear up for ‘BE’ release 

EXCLUSIVE: "She's looking beautiful in the shot and it works very well with her personality" - Dabboo Ratnani on shooting with Ananya Panday for his annual calendar

EXCLUSIVE: Tadap actress Tara Sutaria would like to raid Deepika Padukone’s wardrobe; says ‘she is very chic’